ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS)


$0.24
+0.0073 ( +3.21% ) 876.7K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$0.24

Previous close


$0.23

Volume


876.7K

Market cap


$5.49M

Day range


$0.21 - $0.24

52 week range


$0.14 - $1.66

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 1 Jan 16, 2024
pre Proxies and info statements 4 Jan 05, 2024
8-k 8K-related 15 Nov 29, 2023
10-q Quarterly Reports 62 Nov 09, 2023
8-k 8K-related 14 Nov 09, 2023
4 Insider transactions 1 Nov 08, 2023
8-k 8K-related 12 Oct 13, 2023
8-k 8K-related 14 Oct 05, 2023
8-k 8K-related 14 Sep 22, 2023
8-k 8K-related 15 Aug 07, 2023

Latest News